Cantitate/Preț
Produs

Clinical Trials in Latin America: Where Ethics and Business Clash: Research Ethics Forum, cartea 2

Editat de Nuria Homedes, Antonio Ugalde
en Limba Engleză Hardback – 13 dec 2013
The outsourcing of clinical trials to Latin America by the transnational innovative pharmaceutical industry began about twenty years ago. Using archival information and field work in Argentina, Brazil, Costa Rica, Mexico and Peru, the authors discuss the regulatory contexts and the ethical dimensions of human experimentation in the region. More than 80% of all clinical trials in the region take place in these countries, and the European Medicines Agency has defined them as priority countries in Latin America. The authors raise questions about the quality of data obtained from the trials and the violation of human rights during their implementation. Their findings are presented in this volume, the first in-depth analysis of clinical trials in the region. ​
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 92919 lei  43-57 zile
  Springer International Publishing – 17 sep 2016 92919 lei  43-57 zile
Hardback (1) 93510 lei  43-57 zile
  Springer International Publishing – 13 dec 2013 93510 lei  43-57 zile

Din seria Research Ethics Forum

Preț: 93510 lei

Preț vechi: 114036 lei
-18% Nou

Puncte Express: 1403

Preț estimativ în valută:
17896 18644$ 14879£

Carte tipărită la comandă

Livrare economică 10-24 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319013626
ISBN-10: 3319013629
Pagini: 308
Ilustrații: XVI, 291 p. 9 illus.
Dimensiuni: 155 x 235 x 22 mm
Greutate: 0.61 kg
Ediția:2014
Editura: Springer International Publishing
Colecția Springer
Seria Research Ethics Forum

Locul publicării:Cham, Switzerland

Public țintă

Research

Cuprins

Introduction; Núria Homedes and Antonio Ugalde.- A Review and Critique of International Ethical Principles;Núria Homedes and Antonio Ugalde.- Globalization and Clinical Research in Latin America; Núria Homedes and Antonio Ugalde.- The Regulatory Framework and Case Studies from Argentina; Antonio Ugalde and Núria Homedes .- Politics and Clinical Trials in the Province of Cordoba; Antonio Ugalde and Núria Homedes.-  Brazil:  The System for the Protection of Voluntary Participants in Research; Corina Bontempo D de Freitas, William Saad Hossne and Susie Dutra.- Progress and Challenges of Clinical Research with New Medications in Brazil;Corina Bontempo D de Freitas and Bruno Schlemper Junior.- A Small Country for Big Pharma: Costa Rica; Antonio Ugalde and Núria Homedes.- Cervical Cancer and the Development of HPV Vaccines in Guanacaste, Costa Rica; Núria Homedes and Antonio Ugalde.- Ethical Guidelines for Clinical Trials in Mexico:  Theory and Practice; Emma Verástegui and Edith Valdés-Martínez.- Who Decides? Informed Consent among Cancer Patients in México; Alonso Cerdán, Alejandro González and Emma Verástegui.- A View from Inside: Regulation and Ethical Conflicts in Peru;
Gabriela Minaya Martínez, Susi Olave Quispe and Duilio Fuentes Delgado.- Conclusion; Antonio Ugalde and Núria Homedes.

Textul de pe ultima copertă

The outsourcing of clinical trials to Latin America by the transnational innovative pharmaceutical industry began about twenty years ago. Using archival information and field work in Argentina, Brazil, Costa Rica, Mexico and Peru, the authors discuss the regulatory contexts and the ethical dimensions of human experimentation in the region. More than 80% of all clinical trials in the region take place in these countries, and the European Medicines Agency has defined them as priority countries in Latin America. The authors raise questions about the quality of data obtained from the trials and the violation of human rights during their implementation. Their findings are presented in this volume, the first in-depth analysis of clinical trials in the region. ​

Caracteristici

First book to give an overview of the outsourcing of clinical trials in Latin America Raises questions about the quality of data obtained from the trials and the violation of human rights during their implementation Addresses the economic reasons as to why clinical trials happen more frequently in certain parts of the world?